E M / k C l l / h . l l !be Regional Couunlttee, Having held t e c U c a l discussions on t he problem of poliomyelitis; Noting t h a t serological and virological surveys mde i n the l a s t few years i n a number of countries i n the Eastern Mediterranean Region have confirmed the high endemicity of the disease; Recognizing that the general methods of oontrol a s applied t o many infect ious diseases have been found t o be of l i t t l e ava i l i n the oontrol of poliomyelitis, and t h a t there is general agreement, a t present, t ha t act ive inmunization of t he susceptible population i n a coumunity is the only effect ive method of prevention and control of poliomyelitis; Considering that effect ive innunization against poliomyelitis i s possible today with e i t he r inactivated o r l i v e attenuated pol iovims vaccines; Realizing that l i v e attenuated poliovirus vaccine has t he advantage of being taken by mouth and there is a strong indication t h a t it gives a better, more complete and l a s t i ng i n a n i t y , t h a t it is eas ie r and cheaper t o adndnister, does not require par t icular ly well-developed medical organization o r great financial resources and i s therefore well-adapted t o countries of the Region; Recognizing, however, t h a t ce r ta in questions re la ted t o l i v e vaccine have not ye t been answered and a n u m b e r of problems have yet t o be solved before t he unlimited use of this l i v e vaccine can be recomnended, 1. COhWNEi the Regional Mrec tor on the comprehensive documentation submitted t o the Regional C o d t t e e i 2. REITERATES the importance of promoting the system of reporting poliomyelitis i n t he countries of the Region i n order t o have a t r u e picture of t he epidendological s i tuat ion; 3. RECO- t h a t i n countries where poliomyelitis const i tutes a serious public heal th problem, and where i n t e r e s t i s expressed i n the poss ib i l i ty of developing innunization campaigns with l i v e attenuated poliovirus vaccine well-organized virological and serological services of high technical cal ibre should be established before embarking on any mass vaccination campaign; 4. REC0MMWLI.S t h a t countries whlch have introduced t he inactivated vaccine f o r ths imrunlzation of t h e i r in fan ts and young children should continue f o r the time being t o use this vacoine u n t i l it becomes possible t o s h i f t t o l i v e attermated poliovirus vaccine; 5. REWESTS the Regional Mrector: i. t o a s s i s t Member S ta tes which express t h e i r i n t e r e s t i n launching l i v e attenuated poliovirus vaccination campaiigis, with the development of the virological and serological services required f o r these campaigns; ii. t o co l lec t information on a l l the advances made and the s tudies undertaken on the various questions re la ted t o the l i v e attenuated poliovirus vaccine t ha t have s t i l l t o be anmered. August 1961
World Health Organization (WHO) · Technical Documents
Virus and rickettsial diseases: poliomyelitis [EM/RC11/R.11]
View original document
The full text is hosted by the publishing organisation. lawenc.com indexes the metadata and links to the official source.
Full text
Key facts
Organisation
World Health Organization (WHO)
Document type
Technical Documents
Source
World Health Organization